Pharmacist-led sedative-hypnotic deprescribing in team-based primary care practice.

Eric LuiKimberly WintemuteMaria MuracaChristine TruongRita HaAlbert Kee Buhm ChoeLaura MichellJoanne Laine-GossinHarvey BlankensteinStephanie KleinDana MayerVictor FederMichelle Greiver

Published in: Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC (2021)

Almost two-thirds of patients participating in our pharmacist-led program were able to stop or taper their SH medications by ≥50%. The role of CBT-I in SH deprescribing remains to be further elucidated. Can Pharm J (Ott) 2021;154:xx-xx.

Keyphrases

primary care
end stage renal disease
quality improvement
ejection fraction
chronic kidney disease
newly diagnosed
healthcare
prognostic factors
palliative care